ARCHIVES

FDA Approves Ribavirin Phase 102 Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

Preliminary Report Tends To Support Pill’s Association With Liver Tumors

November 19, 1976

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

November 29, 2013

Survival After Liver Transplant Called Excellent In Study

November 28, 2003

In Brief: Univ. of New Mexico Looked Over As Possible Comprehensive Center; Missouri Asks Delay

November 26, 1976

Senate Confirms McClellan For FDA

October 25, 2002

ASCO, AACR Call NCI Bypass Budget A Key Advocacy Tool, Seek Larger Role In Writing It.

July 14, 2000